Eagle Global Advisors LLC Amgen Inc Transaction History

Eagle Global Advisors LLC

$1.86 Billion
Q2 2024

A detailed history of Eagle Global Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Eagle Global Advisors LLC holds 1,720 shares of AMGN stock, worth $549,677. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,720

Previous 2,720 36.76%

Holding current value

$549,677

Previous $773,000 30.53%

% of portfolio

0.03%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $262,750 - $319,310	-1,000 Reduced 36.76%	1,720 $537,000
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $622,961 - $791,547	2,720 New	2,720 $714,000
Q1 2022 Apr 20, 2022	BUY	$219.27 - $242.57 $190,764 - $211,035	870 New	870 $210,000
Q4 2021 Feb 01, 2022	SELL	$198.88 - $227.6 $10.1 Million - $11.5 Million	-50,535 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $149,438 - $175,084	-704 Reduced 1.37%	50,535 $10.7 Million
Q2 2021 Jul 15, 2021	BUY	$233.58 - $259.14 $36,438 - $40,425	156 Added 0.31%	51,239 $12.5 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $94,311 - $109,905	-425 Reduced 0.83%	51,083 $12.7 Million
Q4 2020 Feb 01, 2021	SELL	$216.38 - $257.67 $375,419 - $447,057	-1,735 Reduced 3.26%	51,508 $11.8 Million
Q3 2020 Oct 22, 2020	SELL	$234.65 - $260.95 $356,433 - $396,383	-1,519 Reduced 2.77%	53,243 $13.5 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $75,959 - $93,212	-384 Reduced 0.7%	54,762 $12.9 Million
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $179,870 - $238,557	987 Added 1.82%	55,146 $11.2 Million
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $246,919 - $317,376	-1,305 Reduced 2.35%	54,159 $13.1 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $151,649 - $181,708	871 Added 1.6%	55,464 $10.7 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $1.69 Million - $1.99 Million	-10,160 Reduced 15.69%	54,593 $10.1 Million
Q1 2019 Apr 22, 2019	SELL	$180.87 - $203.88 $54,984 - $61,979	-304 Reduced 0.47%	64,753 $12.3 Million
Q4 2018 Jan 30, 2019	BUY	$178.4 - $208.25 $6.1 Million - $7.12 Million	34,201 Added 110.84%	65,057 $12.7 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $239,024 - $269,468	1,290 Added 4.36%	30,856 $6.4 Million
Q2 2018 Aug 01, 2018	BUY	$166.05 - $186.51 $61,604 - $69,195	371 Added 1.27%	29,566 $5.46 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $780,055 - $911,592	4,604 Added 18.72%	29,195 $4.98 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $148,535 - $165,959	880 Added 3.71%	24,591 $4.28 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $3.97 Million - $4.53 Million	23,711	23,711 $4.42 Million

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Global Advisors LLC with notifications on news.

Account

Eagle Global Advisors LLC Amgen Inc Transaction History